137 related articles for article (PubMed ID: 29908344)
1. Nitroxide radical-containing nanoparticles attenuate tumorigenic potential of triple negative breast cancer.
Shashni B; Nagasaki Y
Biomaterials; 2018 Sep; 178():48-62. PubMed ID: 29908344
[TBL] [Abstract][Full Text] [Related]
2. Management of tumor growth and angiogenesis in triple-negative breast cancer by using redox nanoparticles.
Shashni B; Nishikawa Y; Nagasaki Y
Biomaterials; 2021 Feb; 269():120645. PubMed ID: 33453633
[TBL] [Abstract][Full Text] [Related]
3. Icariin-induced inhibition of SIRT6/NF-κB triggers redox mediated apoptosis and enhances anti-tumor immunity in triple-negative breast cancer.
Song L; Chen X; Mi L; Liu C; Zhu S; Yang T; Luo X; Zhang Q; Lu H; Liang X
Cancer Sci; 2020 Nov; 111(11):4242-4256. PubMed ID: 32926492
[TBL] [Abstract][Full Text] [Related]
4. The ROS scavenging and renal protective effects of pH-responsive nitroxide radical-containing nanoparticles.
Yoshitomi T; Hirayama A; Nagasaki Y
Biomaterials; 2011 Nov; 32(31):8021-8. PubMed ID: 21816462
[TBL] [Abstract][Full Text] [Related]
5. Tryptophan hydroxylase 1 and 5-HT
Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
[TBL] [Abstract][Full Text] [Related]
6. Application of surface enhanced Raman spectroscopy as a diagnostic system for hypersialylated metastatic cancers.
Shashni B; Horiguchi Y; Kurosu K; Furusho H; Nagasaki Y
Biomaterials; 2017 Jul; 134():143-153. PubMed ID: 28460336
[TBL] [Abstract][Full Text] [Related]
7. KR-33028, a potent inhibitor of the Na
Amith SR; Wilkinson JM; Fliegel L
Biochem Pharmacol; 2016 Oct; 118():31-39. PubMed ID: 27521504
[TBL] [Abstract][Full Text] [Related]
8. Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer.
Liu J; Chen X; Ward T; Pegram M; Shen K
Tumour Biol; 2016 Jul; 37(7):9825-35. PubMed ID: 26810188
[TBL] [Abstract][Full Text] [Related]
9. Induction of mitochondrial apoptotic pathway in triple negative breast carcinoma cells by methylglyoxal via generation of reactive oxygen species.
Roy A; Ahir M; Bhattacharya S; Parida PK; Adhikary A; Jana K; Ray M
Mol Carcinog; 2017 Sep; 56(9):2086-2103. PubMed ID: 28418078
[TBL] [Abstract][Full Text] [Related]
10. Norstictic Acid Inhibits Breast Cancer Cell Proliferation, Migration, Invasion, and In Vivo Invasive Growth Through Targeting C-Met.
Ebrahim HY; Elsayed HE; Mohyeldin MM; Akl MR; Bhattacharjee J; Egbert S; El Sayed KA
Phytother Res; 2016 Apr; 30(4):557-66. PubMed ID: 26744260
[TBL] [Abstract][Full Text] [Related]
11. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
[TBL] [Abstract][Full Text] [Related]
12. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
[TBL] [Abstract][Full Text] [Related]
13. Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer.
Zhao YQ; Yin YQ; Liu J; Wang GH; Huang J; Zhu LJ; Wang JH
Acta Pharmacol Sin; 2016 Sep; 37(9):1237-50. PubMed ID: 27397540
[TBL] [Abstract][Full Text] [Related]
14. Fenton-reaction-stimulative nanoparticles decorated with a reactive-oxygen-species (ROS)-responsive molecular switch for ROS amplification and triple negative breast cancer therapy.
Zhang J; Zuo T; Liang X; Xu Y; Yang Y; Fang T; Li J; Chen D; Shen Q
J Mater Chem B; 2019 Dec; 7(45):7141-7151. PubMed ID: 31663577
[TBL] [Abstract][Full Text] [Related]
15. The Na⁺/H⁺ exchanger (NHE1) as a novel co-adjuvant target in paclitaxel therapy of triple-negative breast cancer cells.
Amith SR; Wilkinson JM; Baksh S; Fliegel L
Oncotarget; 2015 Jan; 6(2):1262-75. PubMed ID: 25514463
[TBL] [Abstract][Full Text] [Related]
16. Redox nanoparticle increases the chemotherapeutic efficiency of pioglitazone and suppresses its toxic side effects.
Thangavel S; Yoshitomi T; Sakharkar MK; Nagasaki Y
Biomaterials; 2016 Aug; 99():109-23. PubMed ID: 27235996
[TBL] [Abstract][Full Text] [Related]
17. Deferoxamine Enhanced Mitochondrial Iron Accumulation and Promoted Cell Migration in Triple-Negative MDA-MB-231 Breast Cancer Cells Via a ROS-Dependent Mechanism.
Chen C; Wang S; Liu P
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597263
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumorigenic effects of a novel digitoxin derivative on both estrogen receptor-positive and triple-negative breast cancer cells.
Kulkarni YM; Yakisich JS; Azad N; Venkatadri R; Kaushik V; O'Doherty G; Iyer AKV
Tumour Biol; 2017 Jun; 39(6):1010428317705331. PubMed ID: 28618929
[TBL] [Abstract][Full Text] [Related]
19. Combination Treatment of Murine Colon Cancer with Doxorubicin and Redox Nanoparticles.
Vong LB; Nagasaki Y
Mol Pharm; 2016 Feb; 13(2):449-55. PubMed ID: 26605906
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of G Protein-Coupled Estrogen Receptor by Chrysin-Nanoparticles Inhibits Tumor Proliferation and Metastasis in Triple Negative Breast Cancer Xenograft Model.
Kim KM; Jung J
Front Endocrinol (Lausanne); 2020; 11():560605. PubMed ID: 33042020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
